Funded Tech Companies
Emendo Biotherapeutics
Looking for the VC firms that invested in Emendo Biotherapeutics? Private investors and Anges Quebec joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Emendo Biotherapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
400 W 61st St.
New York, NY 10069
USA
New York, NY 10069
USA
Phone
Website
Email Address
Company Background Information
Overview
Emendo Biotherapeutics is a pioneering, next generation CRISPR company. Our unique approach allows us to make any gene targetable, transforming the current landscape of genetic medicine.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/17/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Baram
Chief Medical Officer
Todd Wider
Executive Vice President
Rachel Diamant
VP - R & D
Asael Herman
Company Investors
- Anges Quebec
Browse more funded tech companies:
eMed Technologies | Emerald Exam
Share this article
About Our VC Transaction Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs